NLRP3 (rs10754558) gene polymorphism and tumor necrosis factor alpha as predictors for disease activity and response to methotrexate and adalimumab in psoriasis.

BMC Immunol · 2024 · PMC11223426 · PMID 38965465

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Results There was a highly significant difference in NLRP3 genotypes and alleles distribution between psoriasis patients and controls ( P = 0.002,0.004).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.